BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28672769)

  • 1. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy.
    Joosen AMCP; van der Linden IJM; Schrauwen L; Theeuwes A; de Groot MJM; Ermens AAM
    Clin Chem Lab Med; 2017 Nov; 56(1):113-119. PubMed ID: 28672769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH and fT4 during pregnancy: an observational study and a review of the literature.
    Joosen AM; van der Linden IJ; de Jong-Aarts N; Hermus MA; Ermens AA; de Groot MJ
    Clin Chem Lab Med; 2016 Jul; 54(7):1239-46. PubMed ID: 26641966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon.
    Lippi G; Schena F; Salvagno GL; Sanchis-Gomar F; Guidi GC
    J Clin Lab Anal; 2015 Jan; 29(1):15-20. PubMed ID: 24659530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population.
    Krintus M; Kozinski M; Braga F; Kubica J; Sypniewska G; Panteghini M
    Clin Chem Lab Med; 2018 Jun; 56(7):1161-1168. PubMed ID: 29432202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in preeclampsia at triage.
    Wellmann S; Benzing J; Fleischlin S; Morgenthaler N; Fouzas S; Bührer CA; Szinnai G; Burkhardt T; Lapaire O
    Fetal Diagn Ther; 2014; 36(3):202-7. PubMed ID: 24853905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide.
    Zurek M; Maeder MT; Brutsche MH; Lüthi A; Twerenbold R; Freese M; Rickli H; Mueller C
    Eur J Appl Physiol; 2014 Apr; 114(4):815-24. PubMed ID: 24390725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections.
    Michels M; Djamiatun K; Faradz SM; Koenders MM; de Mast Q; van der Ven AJ
    J Clin Virol; 2011 Jan; 50(1):8-12. PubMed ID: 20952250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
    Koch L; Dabek MT; Frommhold D; Poeschl J
    Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study.
    Schnabel RB; Wild PS; Schulz A; Zeller T; Sinning CR; Wilde S; Kunde J; Lubos E; Lackner KJ; Warnholtz A; Gori T; Blankenberg S; Munzel T;
    Hypertension; 2012 Aug; 60(2):288-95. PubMed ID: 22689741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midregional pro-adrenomedullin plasma concentrations are blunted in severe preeclampsia.
    Matson BC; Corty RW; Karpinich NO; Murtha AP; Valdar W; Grotegut CA; Caron KM
    Placenta; 2014 Sep; 35(9):780-3. PubMed ID: 25043691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes.
    Smith J; Halse KG; Damm P; Lindegaard ML; Amer-Wåhlin I; Hertel S; Johansen M; Mathiesen ER; Nielsen LB; Goetze JP
    Biomark Med; 2013 Feb; 7(1):139-46. PubMed ID: 23387495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
    Frøssing S; Nylander M; Aziz M; Skouby SO; Kistorp C; Faber J
    Gynecol Endocrinol; 2017 Jan; 33(1):30-33. PubMed ID: 27424881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
    Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.